TG Therapeutics Inc (NAS:TGTX)
$ 30.1 -1.345 (-4.28%) Market Cap: 4.69 Bil Enterprise Value: 4.60 Bil PE Ratio: 0 PB Ratio: 24.39 GF Score: 74/100

Q3 2024 TG Therapeutics Inc Earnings Call Transcript

Nov 04, 2024 / 01:30PM GMT
Release Date Price: $24.36 (-9.44%)
Operator

Greetings and welcome to the TG Therapeutics third quarter conference call and webcast. At this time, all participants are in listen-only mode.

If anyone should require operator assistance, please press star zero on your telephone keypad.

A question-and-answer session will follow the formal presentation. You may be placed in the question queue at any time by pressing star one on your telephone keypad. As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Jenna Bosco. Please go ahead.

Jenna Bosco
TG Therapeutics Inc - Senior Vice President - Corporate Communications

Thank you, welcome everyone and thanks for joining us this morning. I'm Jenna Bosco and with me today to discuss the third quarter, 2024 financial results are Michael Weiss, our Chairman and Chief Executive Officer, Adam Waldman, our Chief Commercialization Officer and Sean Power, our Chief Financial Officer following our safe harbor statement. Mike will provide an overview of our recent corporate developments.

Adam will share an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot